Background Catheter-based systems are being developed to deliver drugs directly into the vessel wall. Pressure-mediated trauma and lack of homogeneous delivery are key limitations of these approaches.
the drug throughout the entire circumference of the arterial wall within the intima, media, and adventitia. lontophoresismediated vessel wall trauma was minimal (less than 10% endothelial denudation and medial smooth muscle cell damage). Balloon injury after local delivery changed neither kinetics nor distribution of the drug into the arterial wall.
Conclusions ( The local drug delivery catheter used in the present study incorporated an iontophoretic mechanism to facilitate drug delivery. lontophoresis is a form of drug delivery that uses electrical current to enhance the movement of charged molecules across or through tissue. The catheter system was developed by CorTrak Medical, Inc. It consists of a 7F catheter that includes a porous balloon with impermeable ends. The balloon used in this study was 5 mm in diameter, and its working length (permeable region) was 30 mm. An inflation pressure of 2 to 3 psi (0.1 to 0.2 atm) was used to expand the balloon, thus allowing contact of the porous membrane with the vessel wall. During the delivery procedure, the drug solution was recirculated through the balloon catheter at a flow rate of 1 to 2 mL/min with the use of a Masterflex peristaltic pump model 7013 (Cole-Parmer Instrument Co). The balloon includes an Ag-AgCl electrode that serves as the cathode. An adhesive electrode patch (lOx16 cm) placed on the skin serves as the anode. A constant-current density of 4 mA/cm2 was used to drive the charged drug molecules through the porous membrane into the arterial wall.
Experimental Procedure
All procedures performed in this study were approved by the appropriate institutional review committee and conformed 
Radiolabeling of r-Hirudin
Recombinant desulfatohirudin (r-hirudin, CG39393, CIBA-GEIGY) was labeled with`2I using the chloramine-T method. 7 In brief, 1 mCi of carrier-free`I in 50 ,L of 1 mol/L sodium acetate (pH 4) and 30 ,L of 0.1% chloramine-T were added to 0.1 mg of r-hirudin dissolved in 100 ,uL of distilled water. The reaction was stopped by the addition of 50 ,L of sodium metabisulfite. Unreacted iodine was separated from the labeled r-hirudin by gel filtration on a prepacked Sephadex G-25 cartridge (PD10) from Pharmacia. While they were washed with Tris buffer saline, 20 1-mL fractions were collected and counted in a dose gamma calibrator (AtomLab 100). The major radioactive eluates, representing 89.2% of the original activity, were pooled (fractions 3 to 5) and added up to 10 mL of a solution of unlabeled r-hirudin in distilled water (final concentration, 5 mg/mL).
Protocol
Animals were sedated with intramuscular ketamine (20 mg/kg, Ketalar, Parke-Davis) followed by intravenous injection of sodium pentobarbital (10 mg/kg, Sodium Pentobarbital Injection C, Anpro Pharmaceutical). Adequate anesthesia was confirmed by the absence of a limb-withdrawal reflex. Animals were intubated and ventilated with a volume ventilator (Searle). The ECG was continuously recorded. Introducer sheaths (9F and 8F) were placed into the right and left femoral arteries, respectively. Thereafter, each animal received intravenous heparin for anticoagulation (100 IU * kg`h-1 bolus plus infusion). The iontophoretic balloon was advanced under fluoroscopic guidance through the 9F introducer over a 0.014-in. guidewire into either the right or left carotid artery. The balloon was fully inflated to a pressure of 2 to 3 psi by pumping the radiolabeled r-hirudin solution, and complete vessel occlusion was verified by contrast injection through a catheter inserted through the contralateral femoral artery. In total, 20 carotid arteries from 10 normal Yorkshire albino pigs (body weight, 24.3+1.3 kg) were treated by delivering the radiolabeled r-hirudin. In 2 arteries, electrical current was not applied at the time of delivery, so we could test passive diffusion of the drug through the system. In the remaining 18 arteries, a current density of 4 mA/cm2 was used to deliver the drug during 5 minutes of balloon occlusion. Conventional balloon angioplasty was performed after delivery (lasting 5 minutes) in 8 arteries to assess the kinetics and distribution of the drug into injured vessel wall. To do so, we inflated an 8-mmdiameter balloon (balloon-to-vessel ratio, 1.5 to 2) to 8 to 9 atm during 30 seconds five times in the area previously treated by local delivery. Animals were euthanized with an overdose of sodium pentobarbital, and the carotid arteries were carefully dissected and removed. Experiments were planned to remove simultaneously both carotids from each animal. Two vessels were removed immediately after passive diffusion delivery, four immediately after iontophoresis, four immediately after iontophoresis followed by balloon angioplasty, three 1 hour after iontophoresis, four 1 hour after iontophoresis followed by balloon angioplasty, two 2 hours after iontophoresis, and one 3 hours after iontophoresis (Table) . After 
Results

Determination of r-Hirudin Penetration Into the Vessel Wall
Intravascular levels of r-hirudin into noninjured carotid arteries, measured by iodine activity after iontophoresis with 4 mA/cm2 continuous current for 5 minutes, were 80-fold greater than those achieved by passive diffusion (without electricity) (0.78+±0.38 versus 0.01±0 ,ug * g tissue`mm-, respectively). The arterial tissue levels of r-hirudin declined over time, reaching 0.14+0.04 ,ug g tissue-1. mm-1 at 1 hour, 0.08±0.01 gg g tissue`* mm-1 at 2 hours, and 0.02±0 ,ug* g tissue`mm-1 at 3 hours after delivery (Fig 1) Distribution of r-Hirudin Within the Vessel Wall Autoradiography of an artery excised immediately after r-hirudin delivery revealed many silver grains covering the entire arterial wall (Fig 2A) , indicating that the drug was distributed throughout the intima, media, and adventitia. Although fewer autoradiographic grains were seen in the artery processed 1 hour after drug delivery (Fig 2B) , the drug remained distributed throughout all vessel wall thicknesses. Balloon injury after local delivery did not change the distribution pattern of hirudin within the vessel wall, and the drug similarly was distributed through the entire vessel wall at the sites of arterial injury (Fig 2D and 2E) . lontophoresis-Mediated Vessel Wall Damage
Evans blue stained less than 10% of the intimal surface where the iontophoretic delivery was performed. Scanning electron microscopy showed focal endothelial cell loss (less than 10% of intimal surface) at the site of iontophoretic delivery. Arterial cross sections taken from the treated arterial segments at 4-mm intervals revealed an intact internal elastic lamina, focal medial smooth muscle cell loss, an absence of inflammatory infiltrates, and a normal adventitia (Fig 3) .
Discussion
This is the first demonstration of the in vivo use of the iontophoretic balloon delivery system to locally introduce r-hirudin into an arterial wall. The use of an electrical field enhanced the movement of r-hirudin into the arterial wall by 80-fold compared with passive diffusion delivery, ie, when electrical current was not applied to the system. The fact that r-hirudin was detected by ELISA in the extracts from treated arteries indicates that iontophoresis changes neither the structure of the r-hirudin molecule nor, probably, its functional properties.
Retention of r-hirudin in the vessel wall was time dependent; by 1 hour after delivery, approximately 80% of the drug had left the wall, and by 3 hours later, the levels of r-hirudin in the artery were similar to those achieved by passive diffusion. Balloon angioplasty performed after iontophoretic delivery did not change the kinetics of r-hirudin disappearance from the arterial wall. The reasons that r-hirudin rapidly disappears from the arterial wall are probably related to its pharmacokinetic characteristics. r-Hirudin, administered intravenously, is distributed into the extracellular space and has an average half-life of 1 to 2 hours with renal excretion being its predominant route of clearance.8 Autoradiographs performed in a carotid artery after iontophoretic delivery followed by balloon angioplasty. A, Immediately after iontophoresis in a noninjured segment. Many silver grains are seen covering the entire arterial wall, indicating that the drug is distributed throughout the intima, media, and adventitia. B, One hour after iontophoresis in a noninjured segment. Although many fewer grains are seen, the drug remains distributed throughout the entire wall thickness. C, Control autoradiograph from a section of renal artery not treated by local delivery. Only background grains are seen over the media. D, Immediately after iontophoresis at the angioplasty injury site. The drug is similarly distributed across the vessel wall. E, One hour after iontophoresis at the angioplasty injury site (dark-field micrographs; original magnification, x200).
Eventually, retention of small molecules, such as r-hirudin, might be improved by binding to larger biomolecules. For example, it has been reported that dextranbound hirudin distributed in plasma exhibited a prolonged half-life of 7 hours.9 The kinetics of r-hirudin in an atherosclerotic vessel wall remains unknown.
A common problem in the investigation of local drug delivery systems is arterial damage caused by the deliv- ery systems themselves. Such injury may result in significant neointimal proliferation.10"3l The degree of acute vessel wall damage associated with the use of the iontophoretic balloon system, assessed 48 hours after delivery, was minimal (less than 10% endothelial denudation and only focal smooth muscle cell damage) and less than that observed with either perforated balloon systems123 1or polymer-coated stents.14 In addition, with iontophoresis, r-hirudin was distributed throughout the entire circumference of the artery and penetrated the intima, media, and adventitia.
The need for a relatively long duration of vessel occlusion to achieve high local concentrations of a drug within the vessel wall makes it desirable to use a reperfusion lumen catheter to avoid distal ischemia during delivery. However, shorter delivery times achieved by the use of multiple inflations and drugdelivering periods (ie, two or three inflations lasting 1 
